Niektóre dane dotyczące wirusologii, prionów i immunologii

• Autorzy: Larski Z.

Warianty tytułu

EN

Some new data concerning virology, prions and immunology

• Języki publikacji: PL

Abstrakty

EN

The new drug in hepatitis C virus infection with a potent clinical effect, is an inhibitor of HCV nonstructural protein NS5A, essential component of the viral RNA amplification machinery. Therapeutic vaccines aim to treat HIV infected people by boosting ravaged immune system. They modestly but significantly reduced viral levels in the blood of patients. The species barier in prion transmission. Prion isolates, strains and types - propagated in cell cultures show the hallmarks of Darwinian evolution. Tumor-targeted inhibition of nonsense-mediated mRNA decay (NMD), a new approach to stimulate protective anti-tumor immunity. Identification of new mechanism by which tumors escape the immune system. Chemokine CCL21-secreting tumors shift the host immune response from immunogenic to tolerogenic.

Słowa kluczowe

PL

wirusologia; wirusowe zapalenie watroby typu C; nowe leki; AIDS; szczepionki terapeutyczne; priony; choroby prionowe; odpornosc przeciwnowotworowa

• Wydawca: -
• Czasopismo: Medycyna Weterynaryjna
• Rocznik: 2011
• Tom: 67
• Numer: 01
• Opis fizyczny: s.10-14,bibliogr.

Twórcy

autor

Larski Z.

• ul.Puszkina, 8/10, 10-294 Olsztyn

Bibliografia

• 1. Abbott A.: Therapeutic HIV vaccines show promise. Nature 2010, 466, 539.
• 2. Ambrus J. L.: Let the old people read new books, you read the papers. Karger Gazette 1970, 32, 3-4.
• 3. Angers R. C., Kang H. E., Napier D., Browning S., Seward T., Mathiason C., Balachander A., McKenzie D., Castilla J., Soto C., Jewell J., Graham C., Hoover E. A., Telling G. C.: Prion strain mutation determined by prion protein conformotional compatibility and primary structure. Science 2010, 328, 1154-1158.
• 4. Barouch D. H.: Challenges in the development of an HIV-1 vaccine. Nature 2008, 455, 613-619.
• 5. Collinge J.: Prion strain mutation and selection. Science 2010, 328, 1111-1112.
• 6. Collinge J., Clarke A. R.: A general model of prion strains and pathogenicity. Science 2007, 318, 930-936.
• 7. Gao M., Nettles R. E., Belema M., Snyder L. B., Nguyen V. N., Fridell R. A., Serrano-Wu M. H., Langley D. R., Sun J.-H., O’Boyle D. R., Lemm J. A., Wang C., Knipe J. O., Chien C., Colonno R. J., Grasela D. M., Meanwell N. A., Hamann L. G.: Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect. Nature 2010, 465, 96-100.
• 8. Heinkenwalder M., Zeller N., Seeger H., Prinz M., Klöhn P. C., Schwarz P., Ruddle N. H., Wessmann C., Aguzzi A.: Chronic lymphocytic inflammation specifies the organ tropism of prions. Science 2005, 307, 1107-1109.
• 9. Li J., Browning S., Mahal S. P., Oelschlegel A. M., Weissmann C.: Darwinian evolution of prions in cell culture, Science 2010, 237, 869-872.
• 10. Murray C. L., Rice C. M.: An unsuspected drug target. Nature 2010, 465, 42-44.
• 11. Pastor F., Kolonias D., Giangrande P. H., Gilboa E.: Induction of tumour immunity by targeted inhibition of nonsense-mediated mRNA decay. Nature 2010, 465, 227-230.
• 12. Shields J. D., Kourtis I. C., Tomei A. A., Roberts J. M., Swartz M. A.: Induction of lymphoidlike stroma ond immune escape by tumors that express the chemokine CCL21. Science 2010, 328, 749-752.
• 13. Szpechciński A., Stępień A., Izdebska M., Grzanka A., Jaśkowski J. M.: Zastosowanie aptamerów w diagnostyce encefalopatii gąbczastych zwierząt. Medycyna Wet. 2007, 63, 1159-1162.
• 14. Zindl C. L., Chaplin D. D.: Tumor immune evasion. Science 2010, 328, 697-698.